Cancer Research Institute

The Cancer Research Institute (CRI) is a nonprofit organization dedicated exclusively to advancing cancer immunotherapy through rigorous scientific research and global collaboration.

Since 1953, CRI has been instrumental in uncovering the fundamental biology of the immune system and its application to cancer treatment, laying the groundwork for breakthroughs such as checkpoint blockade, cancer vaccines, and engineered cell therapies.

CRI’s mission is to create a world immune to cancer by driving scientific discovery, accelerating collaboration, and turning breakthroughs into lifesaving treatments. Our work bridges the gap between discovery and patient impact, ensuring that scientific innovation translates into real-world treatments.

Subscribe for inspiring patient stories, research breakthroughs, and expert conversations that show how immunotherapy is changing the future of cancer treatment.